Michelle R. Campbell

Associations of amyloid and neurodegeneration plasma biomarkers with comorbidities

Jeremy A. Syrjanen, Michelle R. Campbell, Alicia Algeciras‐Schimnich et al. · Alzheimer s & Dementia · 2021 · 252 citations · Full text

Life Sciences, Clinical Sciences, Neurology +16

Association of plasma glial fibrillary acidic protein (GFAP) with neuroimaging of Alzheimer's disease and vascular pathology

Dror Shir, Jonathan Graff‐Radford, Ekaterina I. Hofrenning et al. · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · 2022 · 123 citations · Full text

Medicine, Neurology, Neuroscience +14

Comparison of plasma neurofilament light and total tau as neurodegeneration markers: associations with cognitive and neuroimaging outcomes

Jordan D. Marks, Jeremy A. Syrjanen, Jonathan Graff‐Radford et al. · Alzheimer s Research & Therapy · 2021 · 82 citations · Full text

Medicine, Neurology, Neuroscience +17

P‐tau/Aβ42 and Aβ42/40 ratios in CSF are equally predictive of amyloid PET status

Michelle R. Campbell, Susan Ashrafzadeh‐Kian, Ronald C. Petersen et al. · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · 2021 · 78 citations · Full text

Medicine, Neurology, Neuroscience +17

Linking Hematopoiesis to Endochondral Skeletogenesis through Analysis of Mice Transgenic for Collagen X

Olena Jacenko, Douglas Roberts, Michelle R. Campbell et al. · American Journal Of Pathology · 2002 · 52 citations

Life Sciences, Cell Biology, Hematology +11